FAST NEWS: Junshi Biosciences Revenue Doubles, Loss Narrows in 2021
The latest: Shanghai Junshi Biosciences Co. Ltd. (1877.HK) announced its 2021 preliminary annual results on Friday evening, reporting its loss narrowed 55.7% last year to 739 million yuan ($116 million),…
RELATED ARTICLES
-
As Covid drug cash dwindles, Vigonvita targets new remedies
-
BRIEF: Burning Rock returns to revenue growth as loss narrows
BNR.US
-
Vanke bleeds red ink but detects signs of upturn
2202.HK 000002.SHE
-
Fenbi chalks up loss as edtech scrambles into AI
2469.HK
-
Country Garden’s debt restructure hinges on stabilizing property market
2007.HK
-
Horizon’s lead grows in smart driving race with new product rollouts
9660.HK
-
Ultraman lifts Bloks Group to new heights in first post-IPO report
0325.HK
